Max Robotics — Global Service Robot Directory + US Certification

About

Alessandro Buda is a leading gynecologic oncologist whose research focuses on refining surgical approaches for gynecologic cancers, particularly cervical and endometrial malignancies. He is best known for his pivotal role in the landmark 2018 study "Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer," which has garnered over 1,850 citations. This work provided critical evidence comparing survival outcomes between minimally invasive and open surgery for early-stage cervical cancer, sparking widespread clinical debate and influencing global treatment guidelines. Buda has also advanced sentinel lymph node mapping techniques, demonstrating the feasibility of hand-assisted laparoscopic sentinel node biopsy during open endometrial cancer surgery—a contribution that, while smaller in citation count, reflects his commitment to integrating innovative technologies into standard practice. His ongoing SLYMEC II study (2025) investigates the prognostic impact of lymphovascular space invasion in early-stage endometrioid endometrial cancer, further solidifying his expertise in risk stratification. Through these contributions, Buda has helped shape modern surgical oncology, balancing oncologic safety with minimally invasive benefits.